Actualités
Presentation at the ISSWSH 2025
Pelvipharm and Otrera Medical Inc at the ISSWSH Meeting in Atlanta, USA, February 27 – March 2, 2025.
Harin Padma-Nathan will present a digital poster during the poster session entitled “Clinical Trials / Novel Drugs, Methods and Technologies / Basic Science”.
“Relaxant Effects of Cannabidiol on Electrical Field Stimulation-induced Smooth Muscle Contractility of Vaginal Strips from Normal and Oophorectomized Rats”
Padma-Nathan, H; Frid, M; Gorny, D; Assaly, R; Behr-Roussel, D.
Please reach out if you want to discuss our results and potential applications for you.
Happy New Year from Pelvipharm!
As we step into 2025, the Pelvipharm SAS team extends its heartfelt gratitude to all our collaborators, partners, and clients. Thank you for making 2024 an exceptional year! Your trust and support have been the cornerstone of our achievements.
Looking forward, we are thrilled to continue this journey together. Building on last year’s successes, we aim even higher in 2025 with unwavering dedication to innovation and excellence. Let’s make this year remarkable!
Presentation at the ICS 2024
Presentation at the Congress of the ICS 2024 (International Continence Society) in Madrid, Spain, 23-25 October, 2024.
Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:
Presentation at the ESSM 2024
Pelvipharm at the Congress of the ESSM (European Society for Sexual Medicine) in Bari, Italy, 8-10 February, 2024.
François Giuliano will present one abstract during the podium session entitled “Basic science”:
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
Presentation at the SMSNA 2023
- François Giuliano will present one abstract :
“Overview of nonclinical studies of LIB-01, a novel promising oral drug under development for treatment of erectile dysfunction”.
François Giuliano, Diane Gorny, Mahita Razanakolona, Delphine Behr-Roussel, Rana Assaly, Charlotta Gauffin
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
Presentations at the WCE 2023
Pelvipharm at the 15th World Congress on Endometriosis in Edinburg, May 3rd-6th, 2023.
- Delphine Behr-Roussel will present :
” Effect of estrous cycle stage on establishment of a endometriosis rodent model to evaluate the effect of new therapeutic strategies ”
R. Assaly, S. Compagnie, L. Allimonnier, M. Bracconi, F. Giuliano, L. Alexandre, D. Behr-Roussel.
Please come and see us, we will be happy to discuss our results with you and potential applications for you.
Presentation at the ICS 2023
Presentation at the International Continence Society in Toronto, September 27th-29th, 2023.
- Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:
” Intravesical administration of EG110A, a novel nonreplicative Herpes Simplex Virus (HSV-1)-derived vector expressing the light chain of botulinum toxin F, inhibits C-type fibers in an acute intravesical capsaicin rat model ”
Ratelade J1, Faugeroux J2, Behr-Roussel D2, Epstein A1, Denys P3, Giuliano F3, Haag-Molkenteller C1, Salot S1.
1. EG427, 2. Pelvipharm, 3. Université Versailles Saint-Quentin/Paris Saclay/Faculty of Medicine, Neuro-uro-andrology R. Poincaré academic hospital/APHP,
